All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Security
Security
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

Critical Review of "The Cholesterol Wars": Questioning Steinberg's Treatment of the Lipid Hypothesis Debate

By

Follow the author

14d ago· 24 min readenReview

Summary

A critical review of Daniel Steinberg's book "The Cholesterol Wars: The Skeptics vs the Preponderance of Evidence." The reviewer argues that Steinberg dismisses legitimate skepticism about the lipid hypothesis (the theory linking cholesterol to heart disease) as "exaggerated," while being insufficiently critical of low-quality evidence that supports his position. The reviewer contends that Steinberg applies double standards—accepting weak evidence that backs his case while being overly critical of opposing views.

Source

Twitter / XCritical Review of "The Cholesterol Wars": Questioning Steinberg's Treatment of the Lipid Hypothesis Debateamazon.com

Key quotes

· 4 pulled
Steinberg at the beginning mentions 'exaggerated skepticism' and 'totality of the evidence'.
The suggestion is that those who do not believe in the lipid hypothesis were overly cautious and have not looked at the totality of the evidence, which is not true at all.
One has to keep high standards, but not so high as to stifle the growth of knowledge.
He is rarely critical of anything that seems to support his case even if it may be of poor quality, but is critical of anything that he d
Snippet from the RSS feed
The Cholesterol Wars: The Skeptics vs the Preponderance of Evidence [Daniel Steinberg] on Amazon.com. *FREE* shipping on qualifying offers. The Cholesterol Wars: The Skeptics vs the Preponderance of Evidence

You might also wanna read

Comments

Sign in to join the conversation.

No comments yet. Be the first.